BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2003
View Archived Issues
Radiolabeled neuropeptide Y5 receptor antagonists for brain imaging
Read More
Novel viral polymerase inhibitors identified at Boehringer Ingelheim
Read More
New antiinflammatory IKK-2 inhibitors in early development at AstraZeneca
Read More
Significant milestones reached in 2002 at NeuroSearch
Read More
New data on the pharmacokinetics and safety of ciclesonide
Read More
Pain relief induced by intravenous amantadine in diabetic peripheral neuropathy
Read More
Bryostatin-1 increases survival in advanced renal cell carcinoma
Read More
Bayer claims novel glucose- and triglyceride-lowering agents for diabetes and other uses
Read More
Novel HDAC inhibitors in Roche development pipeline
Read More
New antibacterial oxazolidinones in early development at Cipla
Read More
Aventis scientists design new imidazolidine-based VLA-4 antagonists
Read More
Inex: 2002 results, 2003 milestones
Read More
Yuhan granted marketing rights to prulifloxacin in Korea
Read More
ML-04 shows efficacy in chronic prostatitis
Read More
Low-dose Prempro approved by FDA
Read More
NCI grant for trial of NCX-4016 in prevention of colon cancer
Read More
Maxim receives NCI SBIR grant for MX-2167
Read More
DP-109 reduces beta-amyloid plaque deposition in models of Alzheimer's disease
Read More
Phase II DX-88 study in angioedema completes patient treatment
Read More
BAL-5788 receives fast track designation for cSSSI
Read More
ARISE phase III protocol adequate to support AGI-1067 NDA
Read More
Licensing activity update for Zindaclin
Read More
FDA approves first fusion inhibitor for HIV infection
Read More
Fesoterodine pharmacodynamics and pharmacokinetics after multiple oral doses in man
Read More
GSK celebrates the international launch of Avodart
Read More
Bladder selectivity demonstrated in preclinical and clinical studies with YM-905
Read More
Results from European phase III trial of Plenaxis discussed at EAU meeting
Read More